Companies / BAX vs SOLV
BAX vs SOLV: Baxter International and Solventum
Baxter International (BAX) reported $11.2B in revenue against a -8.5% net margin, while Solventum (SOLV) reported $8.3B at a 18.7% net margin, most recently.
| Metric | BAX | SOLV |
|---|---|---|
| Revenue | $11.2B | $8.3B |
| Net Income | $-1.0B | $1.6B |
| Gross Margin | 30.1% | 53.5% |
| Operating Margin | -2.7% | 26.2% |
| EPS (Diluted) | $-1.87 | $8.88 |
| Free Cash Flow | $0.3B | $-10.0M |
| Total Debt | $9.5B | $5.0B |
| P/E Ratio | n/m | 8.9× |
| P/B Ratio | n/m | 2.7× |
| Stock Price | $25.64 | $87.11 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BAX Revenue | $10.1B | $10.4B | $10.6B | $11.2B |
| SOLV Revenue | $8.1B | $8.2B | $8.3B | $8.3B |